Through our tried-and-tested model for stimulating essential healthcare companies to do more to reach people in low- and middle-income countries, the Access to Medicine Foundation has had a demonstrable impact on expanding access to medicine.
An interview with Stephanie Niven, Portfolio Manager at Ninety One
The interview shines a light on how Ninety One, an investment management firm, is using the Foundation's insights to move essential healthcare companies towards expanding access to medicine in underserved regions.
The Foundation's progress in advancing access to medicine
Our work has already made a significant contribution to advancing the pharmaceutical industry’s engagement with access issues. In 2024, the Access to Medicine Foundation commissioned an independent evaluation of our progress in advancing access to medicine in low- and middle-income countries.
The evaluation concluded that "the work of the Foundation is highly relevant and unique in the global health ecosystem. The Foundation has a strong influence on corporate approaches to access and has significantly contributed to improving access to medicines in low-and middle-income countries."Â This confirmed the validity of our three-part model for change and the effectiveness of the mechanisms we use to mobilise the healthcare industry to improve access.
“When I talk to executives from pharmaceutical companies they tell me that they want to do more for neglected diseases, but they at least need to get credit for it. The Access to Medicine Index does exactly that.”
Bill Gates
Co-chair and Trustee, Bill & Melinda Gates Foundation
What global health stakeholders say about the impact of our work
Discover what our global health partners have to say about the Foundation's changemaking efforts and its impact on improving access to medicine worldwide.
“Africa has been overlooked when it comes to research and development of life-saving medical commodities, including COVID-19 vaccines. Free market demand and supply principles will not work on their own without an equitable access dimension. The Access to Medicine Foundation is important for accountability – tracking how and where healthcare companies live up to their commitments; as well as encouraging them to do better – in bridging gaps in equitable access to health products and achieving universal health coverage.”
An interview with Frank Wagemans, Senior Engagement Specialist at Achmea IM
He shines a light on how his investment management firm is using the Foundation's insights to drive change and move healthcare companies towards expanding access to medicine in low- and middle-income countries.
